Advertisement
Research Article Free access | 10.1172/JCI4285
Department of Pediatric Oncology Dana-Farber Cancer Institute, Children's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA. kenneth_cook@dfci.harvard.edu
Find articles by Cooke, K. in: JCI | PubMed | Google Scholar
Department of Pediatric Oncology Dana-Farber Cancer Institute, Children's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA. kenneth_cook@dfci.harvard.edu
Find articles by Hill, G. in: JCI | PubMed | Google Scholar
Department of Pediatric Oncology Dana-Farber Cancer Institute, Children's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA. kenneth_cook@dfci.harvard.edu
Find articles by Crawford, J. in: JCI | PubMed | Google Scholar
Department of Pediatric Oncology Dana-Farber Cancer Institute, Children's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA. kenneth_cook@dfci.harvard.edu
Find articles by Bungard, D. in: JCI | PubMed | Google Scholar
Department of Pediatric Oncology Dana-Farber Cancer Institute, Children's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA. kenneth_cook@dfci.harvard.edu
Find articles by Brinson, Y. in: JCI | PubMed | Google Scholar
Department of Pediatric Oncology Dana-Farber Cancer Institute, Children's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA. kenneth_cook@dfci.harvard.edu
Find articles by Delmonte, J. in: JCI | PubMed | Google Scholar
Department of Pediatric Oncology Dana-Farber Cancer Institute, Children's Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA. kenneth_cook@dfci.harvard.edu
Find articles by Ferrara, J. in: JCI | PubMed | Google Scholar
Published November 15, 1998 - More info
Donor T cell responses to host alloantigen are known predictors for graft-versus-host disease (GVHD); however, the effect of donor responsiveness to an inflammatory stimulus such as lipopolysaccharide (LPS) on GVHD severity has not been investigated. To examine this, we used mouse strains that differ in their sensitivity to LPS as donors in an experimental bone marrow transplant (BMT) system. Lethally irradiated (C3FeB6)F1 hosts received BMT from either LPS-sensitive (LPS-s) C3Heb/Fej, or LPS-resistant (LPS-r) C3H/ Hej donors. Mice receiving LPS-r BMT developed significantly less GVHD as measured by mortality and clinical score compared with recipients of LPS-s BMT, a finding that was associated with significant decreases in intestinal histopathology and serum LPS and TNF-alpha levels. When donor T cell responses to host antigens were measured, no differences in proliferation, serum IFN-gamma levels, splenic T cell expansion, or CTL activity were observed after LPS-r or LPS-s BMT. Systemic neutralization of TNF-alpha from day -2 to +6 resulted in decreased intestinal pathology, and serum LPS levels and increased survival after BMT compared with control mice receiving Ig. We conclude that donor resistance to endotoxin reduces the development of acute GVHD by attenuating early intestinal damage mediated by TNFalpha. These data suggest that the responsiveness of donor accessory cells to LPS may be an important risk factor for acute GVHD severity independent of T cell responses to host antigens.